Peter C. Brandt
CIK: 0001434099
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IN8BIO, INC.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- May 9, 2026INAB
IN8BIO, INC.
Award(A)DirectStock Option (right to buy)
22K shares- - Dec 22, 2025INAB
IN8BIO, INC.
Award(A)Direct72.5K shares at avg. $1.38$100K - May 8, 2025INAB
IN8BIO, INC.
Award(A)DirectStock Option (right to buy)
63.2K shares- - Apr 30, 2025INAB
IN8BIO, INC.
Exercise(M)Direct82K shares at avg. $0.18$15K - Apr 30, 2025INAB
IN8BIO, INC.
Exercise(M)Direct82K shares at avg. $0.18$15K - Apr 27, 2025INAB
IN8BIO, INC.
Award(A)DirectSeries B Warrants (right to buy)
82K shares- - Apr 27, 2025INAB
IN8BIO, INC.
Disposition(D)DirectSeries A Warrants (right to buy)
82K shares- - Apr 27, 2025INAB
IN8BIO, INC.
Award(A)DirectSeries A Warrants (right to buy)
82K shares- - Apr 27, 2025INAB
IN8BIO, INC.
Disposition(D)DirectSeries B Warrants (right to buy)
82K shares- - Dec 19, 2024INAB
IN8BIO, INC.
Award(A)DirectStock Option (right to buy)
49.5K shares- - Oct 4, 2024INAB
IN8BIO, INC.
Disposition(D)DirectSeries A Warrants (right to buy)
82K shares- - Oct 4, 2024INAB
IN8BIO, INC.
Award(A)Direct253.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 9, 2026 | INAB IN8BIO, INC. | Award(A) Stock Option (right to buy) | 22,000 | - | - | Direct |
| Dec 22, 2025 | INAB IN8BIO, INC. | Award(A) | 72,464 | $1.38 | $100,000 | Direct |
| May 8, 2025 | INAB IN8BIO, INC. | Award(A) Stock Option (right to buy) | 63,150 | - | - | Direct |
| Apr 30, 2025 | INAB IN8BIO, INC. | Exercise(M) | 81,967 | $0.18 | $15,115 | Direct |
| Apr 30, 2025 | INAB IN8BIO, INC. | Exercise(M) | 81,967 | $0.18 | $15,115 | Direct |
| Apr 27, 2025 | INAB IN8BIO, INC. | Award(A) Series B Warrants (right to buy) | 81,967 | - | - | Direct |
| Apr 27, 2025 | INAB IN8BIO, INC. | Disposition(D) Series A Warrants (right to buy) | 81,967 | - | - | Direct |
| Apr 27, 2025 | INAB IN8BIO, INC. | Award(A) Series A Warrants (right to buy) | 81,967 | - | - | Direct |
| Apr 27, 2025 | INAB IN8BIO, INC. | Disposition(D) Series B Warrants (right to buy) | 81,967 | - | - | Direct |
| Dec 19, 2024 | INAB IN8BIO, INC. | Award(A) Stock Option (right to buy) | 49,490 | - | - | Direct |
| Oct 4, 2024 | INAB IN8BIO, INC. | Disposition(D) Series A Warrants (right to buy) | 81,967 | - | - | Direct |
| Oct 4, 2024 | INAB IN8BIO, INC. | Award(A) | 253,164 | - | $0 | Direct |
1-12 of 12 transactions
About Brandt Peter C.
Brandt Peter C. (SEC CIK 0001434099) files insider reports with the SEC as Director of IN8BIO, INC. (INAB).
Signal8 holds 6 ownership filings by Brandt Peter C., all Form 4s, filed between Oct 8, 2024 and May 12, 2026. Those filings report 12 transactions, from Oct 4, 2024 to May 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Brandt Peter C.'s filings is in NEW YORK, NY.
Recent filings by Brandt Peter C.
- May 9, 2026: Grant or award of INAB derivative securities (Form 4, code A).
- Dec 22, 2025: Grant or award of INAB shares (Form 4, code A).
- May 8, 2025: Grant or award of INAB derivative securities (Form 4, code A).
- Apr 30, 2025: Option exercises of INAB shares (2 lines, Form 4, code M).
- Apr 27, 2025: Grant or award of INAB derivative securities (Form 4, code A).
Other insiders filing for IN8BIO, INC. (INAB)
- FAIRBAIRN EMILY, Director
- Ho William Tai-Wei, CEO
- Greenwood Luba, Director
- Lamb Lawrence, EVP and CSO
- McCall Patrick, CHIEF FINANCIAL OFFICER
- Epperly Corinne, Director